NESIVINE (NASIVIN) 0,05% NOSE SPRAY 1FL 10 ML

Description

NESIVINE 0.05% Nasal Spray for Adults and School-Aged Children

NESIVINE 0.05% nasal spray is a medication designed to provide quick and effective relief from nasal congestion associated with the common cold. This spray is suitable for adults and school-aged children, with a concentration of 0.05% oxymetazoline, an active ingredient that facilitates breathing by decongesting the nasal passages.

Active Ingredient

• Oxymetazoline: Belonging to the family of alpha-sympathomimetics, oxymetazoline acts directly on the nasal mucosa to reduce inflammation and open the nasal passages, thus allowing for better breathing.

Directions for Use

• Recommended use: For adults, teenagers, and children over 6 years of age, it is advised to apply 2 to 3 sprays in each nostril per day.

Contraindications

• Known hypersensitivity to the components of the spray
• Rhinitis sicca (dryness of the nasal mucosa with crust formation)
• Caution is advised for individuals with cardiovascular disorders, hyperthyroidism, diabetes, pheochromocytoma, or closed-angle glaucoma.

Age Precautions

• Children: The product is not recommended for children under 6 years of age.

Pregnancy and Breastfeeding

• Medical consultation is necessary before using the nasal spray during pregnancy and breastfeeding.

Warnings

• Prolonged use may lead to permanent damage to the nasal mucosa, especially if the product is used for more than 5 to 7 consecutive days.
• Preservatives, such as benzalkonium chloride, can cause swelling of the nasal mucosa after extended use.

Drug Interactions

• It is important to discuss all ongoing medications with a doctor or pharmacist before starting treatment with NESIVINE to prevent interactions.

Packaging

• The product is available in a 10 ml bottle.

NESIVINE 0.05% nasal spray is a reliable solution for those seeking a quick way to relieve nasal congestion. It is crucial to follow the usage instructions and not to exceed the recommended duration of use to avoid adverse effects.

Formerly Nasivin